BioSig Technologies (NASDAQ:BSGM) Price Target Raised to $2.75

BioSig Technologies (NASDAQ:BSGM) had its price objective boosted by Ascendiant Capital Markets from $2.50 to $2.75 in a research note issued to investors on Thursday,Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock.

BioSig Technologies Price Performance

BioSig Technologies stock opened at $1.42 on Thursday. The firm’s 50 day simple moving average is $1.17 and its 200-day simple moving average is $0.82. BioSig Technologies has a fifty-two week low of $0.20 and a fifty-two week high of $5.00.

About BioSig Technologies

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.